Clinical Trials List
2021-03-31 - 2026-11-20
Phase III
Recruiting4
ICD-10C41.0
Malignant neoplasm of bones of skull and face
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9170.0
Malignant neoplasm of bones of skull and face, except mandible
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching-Chan Lin 無
- Ming-Hung Tsai Division of Hematology & Oncology
- Ming-Yu Lien 無
- Chi-Ching Chen 無
- Tzu-Ting Chen 無
- Che-Hung Lin 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
320 participants
